 |
|
|
| |
Tenofovir-based antiviral therapy reduces long-term incidence of hepatocellular carcinoma in chronic hepatitis B
|
| |
| |
European Association for the Study of the Liver (EASL) 2024; June 5-8, 2024; Milan, Italy
W. Ray Kim1, Young-Suk Lim2, Harry L.A. Janssen3,4, Sang Hoon Ahn5, Ira Jacobson6, Masashi Mizokami7, Grace Wong8, Frida Abramov9, Leland J. Yee9, Hongyuan Wang9, Catherine Frenette9,10, John F. Flaherty9, Scott K. Fung11, Patrick Marcellin12, Wai-Kay Seto13, Kosh Agarwal14, Jinlin Hou15, Seng Gee Lim16, Jia-Horng Kao17, Maria Buti18,19
|
| |
|
|
|
|
|
